During the past decade, Instituto de Neurologia de Curitiba (INC) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto de Neurologia de Curitiba (INC)" are "Dravet Syndrome (DS)" (2 trials) and "Lennox Gastaut Syndrome (LGS)" (2 trials). Many other conditions were trialed in "Instituto de Neurologia de Curitiba (INC)" in a lesser frequency.

Most popular intervention types in "Instituto de Neurologia de Curitiba (INC)" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Soticlestat" (3 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Neurologia de Curitiba (INC)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Neurologia de Curitiba (INC)". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Instituto de Neurologia de Curitiba (INC), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Neurologia de Curitiba (INC), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Instituto de Neurologia de Curitiba (INC) has several departments that took part in Clinical trials: "Instituto de Neurologia de Curitiba" - 19 trials